Diplomasi Vaksin Dalam Kerja Sama Indonesia Dengan Tiongkok Di Masa Pandemi Covid-19
Abstract
The Covid-19 pandemic has disrupted all aspects of our life. It forced us to adopt to a new normal situation and take innovative measures in tackling the pandemic in order to survive. Health experts developed vaccines to reduce human death and helped people recover from the virus infection. The development of the vaccines has made a great contribution to global health. Indonesia itself used seven vaccine variants, which have been approved by the government for nationwide use. Among them are sinovac and sinopharm vaccines, which were made by China. China has helped Indonesia in many ways, in the provision of vaccines, and the bilateral relations between Indonesia and China continued to increase. This article shows that the provision of Covid-19 vaccines contributed to the strong relations between Indonesia and China, and this was channelled through what was called vaccine diplomacy. In this article, the author will be using the global politics theory to analyze the issue. Through this article, scholars can identify the challenges and benefits of the cooperation.
KEYWORDS
China; Cooperation; Diplomacy; Indonesia; Vaccine
Downloads
References
Agape, G. C. (2021). Jalur Sutra Kesehatan: Upaya China Mencapai Kepentingan Geopolitik Melalui Diplomasi Vaksin. Transformasi Global, 8(2), 130-142. https://doi.org/10.21776/ub.jtg.2021.008.02.2
Anggraito, H. W. (2022). Upaya Diplomasi Vaksin Indonesia Dalam Menangani Pandemi Covid-19 Di Indonesia (Doctoral dissertation, Universitas Muhammadiyah Yogyakarta).
BBC. (2020, April 2).Virus Corona; Bagaimana China Mengatasi Wabah Covid-19 Melalui Teknologi Tersembunyi, Dengan Penduduk Dilacak Lewat Telepon Genggam. https://www.bbc.com/indonesia/dunia-52141201
Bestari, N.P. (2022, February 18). Sinovac Bicara Cuan Triliunan Rupiah dari Vaksin Covid-19. CNBC. https://www.cnbcindonesia.com/tech/20220201053044-37-311963/sinovac-bicara-cuan-triliunan-rupiah-dari-vaksin-covid-19
Hadyan, R. (2021, September 17). Diplomasi Vaksin Bukan Sekedar Mengamankan Stok Saja. Bisnis.com. https://kabar24.bisnis.com/read/20210917/15/1443771/diplomasi-vaksin-bukan-sekadar-mengamankan-stok-saja
Hanura, M., Susiatiningsih, H., Utomo, T., Rusyadi, R., & Putri, S. U. (2022, February). Managing Common Security: Indonesia-China Cooperation in Handling Covid-19 Pandemic. In Proceedings of the First International Conference on Democracy and Social Transformation, ICON-DEMOST 2021, September 15, 2021, Semarang, Indonesia.
Hermawan, B. (2020, June 6). Indonesia Dapat Bantuan Penanganan Covid-19 dari China. Republika.co.id. https://www.republika.co.id/berita/qbgtic354/indonesia-dapat-bantuan-penanganan-covid19-dari-china
Heywood, A. (2011). Global Politics. Palgrave Macmillan.
Hidayat, A.A.N. (2020, March 27). 40 Ton Bantuan Alat Kesehatan dari China Tiba di RI. Tempo.co. https://bisnis.tempo.co/read/1324554/40-ton-bantuan-alat-kesehatan-dari-investor-cina-tiba-di-ri
Hidayat, A., Anam, S., & Munir, A. M. (2022). Diplomasi Vaksin: Strategi Indonesia dalam Memperkuat Keamanan Kesehatan Nasional di Tengah Pandemi Covid-19. Indonesian Journal of Global Discourse, 4(1), 17-34. https://doi.org/10.29303/ijgd.v4i1.44
Jayani, D. H. (2021, October 29). Investasi Tiongkok ke Indonesia Capai US$ 2,3 Milliar hingga September 2002. Databoks. https://databoks.katadata.co.id/datapublish/2021/10/29/investasi-tiongkok-ke-indonesia-capai-us-23-miliar-hingga-september-2021
Jemadu, A. (2008). Politik Global dalam Teori dan Praktik. Graha Ilmu.
Julita, L. S. (2020, November 24). RI Kena Banjir Bandang Impor Alkes China, Ini Buktinya!. CNBC Indonesia https://www.cnbcindonesia.com/news/20201124150425-4-204258/ri-kena-banjir-bandang-impor-alkes-china-nih-buktinya
Kementerian Komunikasi dan Informatika Republik Indonesia. (2021, June 20). Sebanyak 10 Juta Dosis Vaksin Kembali Tiba di Indonesia. https://www.kominfo.go.id/content/detail/35149/sebanyak-10-juta-dosis-vaksin-covid-19-kembali-tiba-di-tanah-air/0/berita
Kementerian Luar Negeri Republik Indonesia. (2019, March 26). Kerja Sama Regional. https://kemlu.go.id/portal/id/page/20/kerja-sama-regional
Lee, S.T. (2021). Vaccine diplomacy: nation branding and China’s COVID-19 soft power play. Place Branding and Public Diplomacy, 1-15.
McDonagh, N. (2021). System Rivalry during Pandemic Times: A Political Economy View of Great Power Vaccine Diplomacy. https://dx.doi.org/10.2139/ssrn.3873029
McDonald, J. W. (2002). The need for multi-track diplomacy. Second track/citizens' diplomacy, 49-60.
Nye, J. S. (2008). Public Diplomacy and Soft Power. The ANNALS of the American Academy of Political and Social Science, 616(1), 94–109. doi:10.1177/0002716207311699
Pannier, A. (2020). Bilateral relations. Global Diplomacy: An Introduction to Theory and Practice, 19-33.
Pearson, C. (2021, December 15). China Promotes Vaccines Around The World, but Critics Point to Lower Efficacy. VoAnews.com. https://www.voanews.com/a/china-promotes-vaccines-around-the-world-but-critics-point-to-lower-efficacy-/6355437.html
Rezkisari, I. (2021, August 25). Diplomasi Vaksin Indonesia Dipuji. Republika.co.id. https://republika.co.id/berita/qye5ne328/diplomasi-vaksin-indonesia-dipuji
Sorongan, T. P. (2021, July 15). Menlu Retno Buka-bukaan Soal Diplomasi Vaksin di Era Pandemi. CNBC Indonesia. https://www.cnbcindonesia.com/profil/20210715141003-41-261167/menlu-retno-buka-bukaan-soal-diplomasi-vaksin-di-era-pandemi
Su, Z., McDonnell, D., Li, X., Bennett, B., Šegalo, S., Abbas, J., Cheshmehzangi, A., Xiang, Y.-T. (2021). COVID-19 Vaccine Donations—Vaccine Empathy or Vaccine Diplomacy? A Narrative Literature Review. Vaccines 9(9), 1024. https://doi.org/10.3390/vaccines9091024
The Conversation. (2021, September 10). Diplomasi vaksin Indonesia Perlu Lebih Strategis Bukan Semata Soal Stok Vaksin. TheConversation.com. https://theconversation.com/diplomasi-vaksin-indonesia-perlu-lebih-strategis-bukan-semata-soal-stok-vaksin-167056
Wibowo, E. A. (2020, July 26). 2 Alasan Distribusi Vaksin Covid-19 Belum Merata. Nasionaltempo.co. https://nasional.tempo.co/read/1487322/2-alasan-distribusi-vaksin-covid-19-belum-merata
Wicaksono, R. M. T. A. D., Hirawan, F. B., & Ragamustari, S. K. (2022). An Analysis of Indonesia’s Free and Active COVID-19 Vaccine
Diplomacy. Jurnal Hubungan Internasional, 11(1), 32-45. https://doi.org/10.18196/jhi.v11i1.13087
World Health Organization. ( 2020, March 11). WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
Yang, H., Bin, P., & He, A. J. (2020). Opinions from the epicenter: an online survey of university students in Wuhan amidst the COVID-19 outbreak1. Journal of Chinese Governance, 5(2), 234-248.
Yulianingsih, T. (2021, July 15). Ini 4 Upaya China Lawan Covid-19 Hingga Masuk ke Fase Normal. Liputan6.com. https://www.liputan6.com/global/read/4607827/ini-4-upaya-china-lawan-covid-19-hingga-masuk-ke-fase-normal
Yuniarto,T. (2022, March 15). Politik Luar Negeri Indonesia: Profil, Sejarah, dan Aktualitas. Kompas.com. https://www.kompas.id/baca/paparan-topik/2022/03/15/politik-luar-negeri-indonesia-profil-sejarah-dan-aktualitas
Zaini, K. (2021). China’s Vaccine Diplomacy in Southeast Asia - A Mixed Record. © ISEAS Yusof Ishak Institute. http://hdl.handle.net/11540/13807.
Published
Issue
Section
Copyright (c) 2023 Papua Journal of Diplomacy and International Relations (PJDIR)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
. 
